Chris Evert reveals cancer has returned

The 18-time Grand Slam champion and tennis Hall-of-Famer was first diagnosed in December 2021, before announcing in January 2023 that she was “cancer-free”

Chris Evert, Wimbledon 2022 Tennis – Wimbledon – All England Lawn Tennis and Croquet Club, London, Britain – July 3, 2022 Former player Chris Evert is seen during centre court centenary celebrations || 235127_0074

In a sad turn of events, 18-time Grand Slam champion Chris Evert has said that her cancer has returned.

Evert was first diagnosed with ovarian cancer in December 2021, following a preventative hysterectomy, and then announced that she was “cancer-free” in January 2023.

The former world No 1 has added that the diagnosis was again made at an early stage, and she will now undergo another round of chemotherapy.

“While this is a diagnosis I never wanted to hear, I again feel fortunate it was caught early,” Evert said in a statement released through ESPN, where she works as a commentator and pundit.

“Since I was first diagnosed with cancer two years ago, I’ve been very open about my experience,” Evert continued.

“Based on a PET CT scan, I underwent another robotic surgery this past week. Doctors found cancer cells in the same pelvic region.

“All cells were removed, and I have begun another round of chemotherapy.”

“I encourage everyone to know your family history and advocate for yourself,” Evert added.

“Early detection saves lives. Be thankful for your health this holiday season.”

Evert is widely considered one of the greatest tennis players to have played the sport. A former world No 1 and 18-time Grand Slam champion, her rivalry with Martina Navratilova dominated the women’s game throughout the 1970s and 80s, and is arguably the greatest rivalry in tennis history.

Evert holds the women’s record for the most Roland-Garros title wins with seven, while she is tied with Serena Williams at six US Opens apiece in the open era, and she continues to set a benchmark for success for younger generations.

People in this post

Your comments

Leave a Reply

Your email address will not be published. Required fields are marked *